IRCT20230401057792N1已完成3 期
Comparison of the efficacy and safety of mesotherapy and meso-needling With HAIRCARE medical device class 3 REVITACARE brand in the treatment of male and female pattern androgenic alopecia: A double blinded controlled randomized clinical trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- All
入选标准
- •Men and women with hereditary hormonal hair loss
排除标准
- •Severe allergic reaction to the injection
- •Receiving any topical or systemic medication in the last 3 months for hair loss
研究者
相似试验
尚未招募
4 期
Open labelled, single arm, interventional study of dutasteride injection for androgenetic alopecia.CTRI/2024/03/064041CUTIS Academy of Cutaneous Sciences
招募中
不适用
Effect of Mesotherapy and RF laser in the Treatment of Double chiIRCT20220615055190N1Islamic Azad University100
招募中
4 期
Type II Diabetic STUDYCTRI/2016/01/006486SV Limited270
已完成
2 期
Clinical efficacy study of Meryton syrup on MenorrhagiaCTRI/2019/08/020571Vasu Research Centre VRC61
尚未招募
1 期
Effect of Medohara vati in MedorogaCTRI/2020/06/025899Patanjali Research Institute Haridwar